Keyphrases
T Cells
100%
Tumor
100%
Nanoring
100%
Antigen Receptor
100%
Epithelial Cell Adhesion Molecule (EpCAM)
60%
Bispecific
20%
Solid Tumors
20%
Breast Cancer Cells
20%
Interleukin-2
20%
Nave
20%
MCF-7
20%
Cancer Stem Cells
10%
Immunogenicity
10%
Antibiotics
10%
Cytotoxicity
10%
Cell Surface
10%
Selective Killing
10%
T Cell Activation
10%
Interleukin-6
10%
Leukemia Cells
10%
FDA-approved Drugs
10%
Non-genetic
10%
T Cell Anergy
10%
Pharmacologic
10%
Tumor Tissue
10%
Antibody Response
10%
Tumor Eradication
10%
Biodistribution Studies
10%
Multiple Cancers
10%
Trimethoprim
10%
Lytic Activity
10%
Human Epithelial Cells
10%
Splenic Cells
10%
In Vivo Biodistribution
10%
Clinically Relevant Concentrations
10%
Carcinoma Stem Cells
10%
Multiple Carcinomas
10%
Deactivation
10%
Orthotopic Breast Cancer Model
10%
Medicine and Dentistry
T Cell
100%
Neoplasm
100%
Prosthetics
100%
Lymphocyte Antigen Receptor
100%
Epithelial Cell Adhesion Molecule
60%
CD3 Antigen
40%
Breast Cancer
30%
Cancer Cell
20%
Solid Malignant Neoplasm
20%
MCF-7
20%
Interleukin 2
20%
Cancer Stem Cell
10%
In Vitro
10%
Receptor
10%
Carcinoma
10%
T Cell Activation
10%
Cancer Model
10%
Cell Surface
10%
Infusion
10%
Leukemia Cell
10%
T Cell Receptor
10%
Tumor Necrosis Factor
10%
Biodistribution
10%
Antibody Response
10%
Trimethoprim
10%
Clonal Anergy
10%
Cytotoxicity
10%
Immunogenicity
10%
Interleukin 6
10%
Pharmacology, Toxicology and Pharmaceutical Science
Lymphocyte Antigen Receptor
100%
Neoplasm
100%
Epithelial Cell Adhesion Molecule
60%
CD3 Antigen
40%
Breast Cancer
30%
Solid Malignant Neoplasm
20%
Interleukin 2
20%
Leukemia
10%
Immunogenicity
10%
Malignant Neoplasm
10%
Tumor Necrosis Factor
10%
Receptor
10%
Biodistribution
10%
Cancer Model
10%
Carcinoma
10%
Interleukin 6
10%
Trimethoprim
10%
Cytotoxicity
10%